Phthalates in Medications May Increase Risk of Childhood Cancers
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Bone Cancer
BONE CANCER ADVISOR
FEATURED CONTENT
-
-
PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes. -
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care. -
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic. -
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
BONE CANCER NEWS
Adding Ifosfamide to MAP Provides No Benefit in High-Grade Osteosarcoma
Dinutuximab Plus GM-CSF Falls Short in Recurrent Osteosarcoma
Carboplatin Deemed Acceptable Replacement for Actinomycin-D in Ewing Sarcoma
Standardized Treatment Eliminates Outcome Disparities in Non-Metastatic Osteosarcoma
High-Dose Ifosfamide Bests Topotecan-Cyclophosphamide in Relapsed/Refractory Ewing Sarcoma
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Bone Cancer
Loading... 
Loading...